Table of Contents Table of Contents
Previous Page  71 / 78 Next Page
Information
Show Menu
Previous Page 71 / 78 Next Page
Page Background

DCMS online

. org

Northeast Florida Medicine

Vol. 66, No. 4 2015

71

Inflammatory Bowel Disease

Pancreatic Diseases in Patients with

Inflammatory Bowel Disease

Introduction

Inflammatory Bowel Disease (IBD) includes major

entities such as Crohn’s disease, and ulcerative colitis, but

microscopic colitis (MC), a minor member, is a surging

form of this disease group. Although their etiology is

unknown, and they all have distinct clinic and patho-

logical characteristics, the relationship between IBD and

pancreatic idiosyncrasies has definitely been established

throughout the years.

IBD Classification

Crohn’s Disease

Crohn’s disease is a chronic disorder characterized by

transmural inflammatory skip lesions that involve the en-

tire gastrointestinal tract. Its symptoms are unpredictable

and may include abdominal pain, cramping, diarrhea,

fever, fatigue, anemia, reduced appetite, and weight loss.

1

Ulcerative Colitis

Ulcerative colitis is the chronic inflammation of the

mucosal layer of the colon. Its most common symptoms

Abstract:

Patients with inflammatory bowel disease (IBD)

show an increased risk of pancreatic diseases compared to the

general population, usually taking place in the course of the

malady or sometimes even preceding the diagnosis. This particular

kind of complication is mainly due to therapeutic agents used

in the management of Crohn’s disease (CD), ulcerative colitis

(UC), and microscopic colitis (MC). IBD also displays other

extraintestinal manifestations involving joints, skin, eyes, kidneys,

liver, gallbladder, and lungs. Despite IBD’s unknown etiology,

it is believed to be the result of the interaction of genetics, the

immune system, and environmental factors. Health care providers

and the general population need to identify premature clinical

manifestations of pancreatic affliction to delay progression and/or

sustain a better management of patients with IBD.

include diarrhea, abdominal pain, hematochezia, fatigue,

weight loss, reduced appetite, tenesmus, and fever.

1,2

Microscopic Colitis

Microscopic colitis is an inflammatory condition of

the colon, usually of insidious onset, characterized by

non-bloody, watery, chronic diarrhea.

3-6

Based on the

exhibited histological features, MC is subclassified in

lymphocytic and collagenous colitis. Lymphocytic colitis

is branded as an intraepithelial lymphocytic infiltrate of

>20 cells per high power field, while collagenous colitis

shows a subepithelial collagen band >10 micrometers in

thickness.

3,7-10

Most commonly associated symptoms include fecal

urgency/incontinence, abdominal pain, and nocturnal

episodes.

11,12

Weight loss can be perceived due to fluid

loss, mostly in patients with active disease (≥3 stools or

≥1 watery stool daily); some extreme cases may lose up

to two liters per day.

4,13

Pancreatic Involvement in IBD

The etiology of pancreatic anomalies in IBD appears to

be multifactorial. Contributing factors include medication

used to treat IBD (6-mercaptopurine, azathioprine, corti-

costeroids or 5-ASA agents), duodenal fistulas, anatomic

abnormalities, such as ampullary and duodenal Crohn’s

disease, gallstones, primary sclerosing cholangitis, pancre-

By Martha Arévalo, MD and Jose M. Nieto, DO, FACP, FACG, AGAF

Address correspondence to:

Martha Arévalo, MD

Universidad de Especialidades Espíritu Santo

Km. 2.5 Vía a La Puntilla

Samborondón - Ecuador

Jose M. Nieto, DO

Borland Groover Clinic

4800 Belfort Road

Jacksonville, FL 32256

Email:

drjnieto@yahoo.com